New Enterprise Associates related stories
All articles and analysis
Crossovers tighten the money spigotNon-traditional venture investors have stopped pumping up valuations, but don’t expect them to leave the asset class en mass or for unicorns to disappear
Here’s how to make QSBS work for the entrepreneurial ecosystemIt’s time for Congressional reform to help boost U.S. entrepreneurialism, say three industry insiders
Sleep? There's a nap for thatStartups focused on helping consumers catch some zzzs are raising millions of dollars, as VCs dream of disrupting the bedroom
Annexon nabs $44 mln in Series B led by NEAAnnexon Biosciences closed a $44 million Series B financing led by new investor New Enterprise Associates. Also participating were Correlation Ventures and existing investors including Novartis Venture Fund, Clarus, and Satter Investment Management, LLC. Annexon is pursuing biopharmaceutical therapies for neurodegenerative disorders.
VCs on the Move Jun 21, 2016Summary of recent people moves in the venture community, from Foundation to Partech
- Fintech platform Plaid scores $44 mln Series B
San Francisco-based financial technology platform Plaid has raised $44 million in Series B funding. Goldman Sachs led the round with participation from New Enterprise Associates. According to the company, the capital will be used for growth.
- NEA leads Series A round for Tigera
San Francisco-based Tigera Inc, a networking solutions provider, has raised $13 million in Series A funding. New Enterprise Associates led the round with participation from Wing Venture Capital. In addition to the funding, Ron Bernal, venture partner at NEA, Aaron Jacobson, principal at NEA; and Peter Wagner, founding partner at Wing, have been added to Tigera’s board of directors.
- NEA leads Series A round for Tigera
San Francisco-based Tigera Inc, a networking solutions provider, has raised $13 million in Series A funding. New Enterprise Associates led the round with participation from Wing Venture Capital. In addition to the funding, Ron Bernal, venture partner at NEA, Aaron Jacobson, principal at NEA; and Peter Wagner, founding partner at Wing, have been added to Tigera’s board of directors.
- Mersana Therapeutics snaps up $33 mln
Cambridge, Massachusetts-based biotech company Mersana Therapeutics has closed $33 million in Series C financing. Wellington Management Company led the round with participation from other investors that included Cormorant Asset Management, Arrowpoint Partners, Takeda Pharmaceutical Company Limited, New Enterprise Associates and Rock Springs Capital.